Treatment Persistence and Augmentation Differences Across Second-Line Treatment Strategies Among TNFi Experienced Ulcerative Colitis Patients: TNFi Cyclers vs MOA Switchers-MedSci.cn

Treatment Persistence and Augmentation Differences Across Second-Line Treatment Strategies Among TNFi Experienced Ulcerative Colitis Patients: TNFi Cyclers vs MOA Switchers

Gorritz, M; Tuly, R; Sun, K; Creveling, T; Fischer, D; Bires, N; Johnson, N; Moses, RE; Hull, M; Updhyay, N

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023; 118 (10): S753

科室
- - 订阅+
  - 更多科室
工具
服务